article thumbnail

Developing a first-in-class small molecule drug for inflammatory disease

European Pharmaceutical Review

To ensure an efficient process, MyMD works closely with the contract manufacturing organisation (CMO) focusing on automation and process improvement. All pharmaceutical companies want to save on the cost of production, but not at the expense of quality. This allows us to stay on top of quality control.